145 related articles for article (PubMed ID: 10383835)
1. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
Sorrells DL; Meschonat C; Black D; Li BD
J Surg Res; 1999 Jul; 85(1):37-42. PubMed ID: 10383835
[TBL] [Abstract][Full Text] [Related]
2. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers.
Sorrells DL; Ghali GE; De Benedetti A; Nathan CO; Li BD
J Oral Maxillofac Surg; 1999 Mar; 57(3):294-9. PubMed ID: 10077200
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma.
Li BD; Liu L; Dawson M; De Benedetti A
Cancer; 1997 Jun; 79(12):2385-90. PubMed ID: 9191527
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
5. Progression of eIF4e gene amplification and overexpression in benign and malignant tumors of the head and neck.
Haydon MS; Googe JD; Sorrells DS; Ghali GE; Li BD
Cancer; 2000 Jun; 88(12):2803-10. PubMed ID: 10870064
[TBL] [Abstract][Full Text] [Related]
6. Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line.
DeFatta RJ; Nathan CO; De Benedetti A
Laryngoscope; 2000 Jun; 110(6):928-33. PubMed ID: 10852506
[TBL] [Abstract][Full Text] [Related]
7. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
[TBL] [Abstract][Full Text] [Related]
9. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.
Chen CN; Hsieh FJ; Cheng YM; Lee PH; Chang KJ
J Surg Oncol; 2004 Apr; 86(1):22-7. PubMed ID: 15048676
[TBL] [Abstract][Full Text] [Related]
10. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.
Nathan CO; Liu L; Li BD; Abreo FW; Nandy I; De Benedetti A
Oncogene; 1997 Jul; 15(5):579-84. PubMed ID: 9247311
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
[TBL] [Abstract][Full Text] [Related]
12. Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E overexpression.
Byrnes KW; DeBenedetti A; Holm NT; Luke J; Nunez J; Chu QD; Meschonat C; Abreo F; Johnson LW; Li BD
J Am Coll Surg; 2007 May; 204(5):925-33; discussion 933-4. PubMed ID: 17481512
[TBL] [Abstract][Full Text] [Related]
13. The expression of proto-oncogene eIF4E in laryngeal squamous cell carcinoma.
Liang Z; Lei T; LuYing Z; YuPing G
Laryngoscope; 2003 Jul; 113(7):1238-43. PubMed ID: 12838026
[TBL] [Abstract][Full Text] [Related]
14. Detection of eIF4E gene amplification in breast cancer by competitive PCR.
Sorrells DL; Black DR; Meschonat C; Rhoads R; De Benedetti A; Gao M; Williams BJ; Li BD
Ann Surg Oncol; 1998; 5(3):232-7. PubMed ID: 9607624
[TBL] [Abstract][Full Text] [Related]
15. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
Holm N; Byrnes K; Johnson L; Abreo F; Sehon K; Alley J; Meschonat C; Md QC; Li BD
Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964
[TBL] [Abstract][Full Text] [Related]
16. Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis.
Nathan CO; Franklin S; Abreo FW; Nassar R; de Benedetti A; Williams J; Stucker FJ
Laryngoscope; 1999 Aug; 109(8):1253-8. PubMed ID: 10443829
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
Wolfort R; de Benedetti A; Nuthalapaty S; Yu H; Chu QD; Li BD
Surgery; 2006 Aug; 140(2):161-9. PubMed ID: 16904965
[TBL] [Abstract][Full Text] [Related]
18. Competitive PCR to detect eIF4E gene amplification in head and neck cancer.
Sorrells DL; Ghali GE; Meschonat C; DeFatta RJ; Black D; Liu L; De Benedetti A; Nathan CO; Li BD
Head Neck; 1999 Jan; 21(1):60-5. PubMed ID: 9890352
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
20. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
Nathan CO; Sanders K; Abreo FW; Nassar R; Glass J
Cancer Res; 2000 Jul; 60(13):3599-604. PubMed ID: 10910074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
